Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study.

about

Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study.

Item

http://www.wikidata.org/entity/Q41219108

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Changing utilization of Stavud ...... 06-2013 in the EuroSIDA study.

@en

type

Item

label

Changing utilization of Stavud ...... 06-2013 in the EuroSIDA study.

@en

prefLabel

Changing utilization of Stavud ...... 06-2013 in the EuroSIDA study.

@en

P1476

Changing utilization of Stavud ...... 06-2013 in the EuroSIDA study.

@en

P2093

A Mocroft

http://www.w3.org/2001/XMLSchema#string

A Rakmanova

http://www.w3.org/2001/XMLSchema#string

EuroSIDA in EuroCoord

http://www.w3.org/2001/XMLSchema#string

I Karpov

http://www.w3.org/2001/XMLSchema#string

I Zeltina

http://www.w3.org/2001/XMLSchema#string

J D Lundgren

http://www.w3.org/2001/XMLSchema#string

K Mansinho

http://www.w3.org/2001/XMLSchema#string

M Losso

http://www.w3.org/2001/XMLSchema#string

M Parczewski

http://www.w3.org/2001/XMLSchema#string

N Chentsova

http://www.w3.org/2001/XMLSchema#string

P2860

Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.

Stavudine: an update of its use in the treatment of HIV infection.

Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects.

Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study.

Changes in first-line cART regimens and short-term clinical outcome between 1996 and 2010 in The Netherlands

cART prescription trends in a prospective HIV cohort in rural Tanzania from 2007 to 2011.

Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.

Effectiveness and safety of 30 mg versus 40 mg stavudine regimens: a cohort study among HIV-infected adults initiating HAART in South Africa

P304

533-543

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HIV.12254

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daria Podlekareva

Daniel Grint

P577

2015-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276853344

http://www.w3.org/2001/XMLSchema#string

P698

25988795

http://www.w3.org/2001/XMLSchema#string